Universe PharmaceuticalsUPC +6.86%58 Days Inventory is 94.36 as of Sep. 2025, which is 81% above its 10-year median of 52.18. GuruFocus rates UPC with a GF Score™ of 58/100 and a GF Value™ of $5.22 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 919 Drug Manufacturers companies, Universe Pharmaceuticals ranks better than 86.62% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Universe Pharmaceuticals's Inventory Turnover for the
six
months ended in Sep. 2025 was 1.93.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Universe Pharmaceuticals's Inventory-to-Revenue for the
six
months ended in Sep. 2025 was 0.33.
Universe Pharmaceuticals (NAS:UPC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Universe Pharmaceuticals's Inventory Turnover for the
six
months ended in Sep. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Universe Pharmaceuticals's Inventory to Revenue for the
six
months ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Universe Pharmaceuticals Days Inventory Related Terms
Universe Pharmaceuticals Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
UPC vs CBIH, PRFX, IMCC: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universe Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Universe Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universe Pharmaceuticals (UPC) has a Days Inventory of 94.36 as of Sep. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Universe Pharmaceuticals and its competitors. This is 81% above median its historical median of 52.18. Over the past decade, Universe Pharmaceuticals' Days Inventory has ranged from 35.19 to 196.21. According to the industry distribution chart, Universe Pharmaceuticals ranks #123 out of 919 companies in the Drug Manufacturers industry, placing it in the top 13.4%.
Is Universe Pharmaceuticals' Days Inventory too high?
Universe Pharmaceuticals' current Days Inventory of 94.36 is 81% above median its 10-year median of 52.18. Over the past 10 years, this metric has ranged from a low of 35.19 to a high of 196.21. The Drug Manufacturers industry median Days Inventory is 162.83. Universe Pharmaceuticals' value of 94.36 is 42% below this industry median. Based on the distribution chart, Universe Pharmaceuticals ranks #123 out of 919 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Universe Pharmaceuticals has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Days Inventory compare to CBIH and PRFX?
According to the Drug Manufacturers industry distribution chart, Universe Pharmaceuticals ranks #123 out of 919 companies for Days Inventory. This places Universe Pharmaceuticals in the top 13% of its industry — outperforming the majority of peers. The industry median Days Inventory is 162.83. Universe Pharmaceuticals' value of 94.36 is 42% below this benchmark. Historically, Universe Pharmaceuticals' own Days Inventory has ranged from 35.19 to 196.21 over the past decade. While the company's 10-year median is 52.18 vs. the industry median of 162.83, Universe Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 162.83, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Universe Pharmaceuticals's current Days Inventory of 94.36 is 42% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Universe Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 162.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Universe Pharmaceuticals's current Days Inventory is 94.36, which is 81% above median its own 10-year median of 52.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Possible Value Trap. The stock's GF Value™ is $5.22, compared to a current price of $2.96 — trading 43.3% below its estimated fair value. The current Days Inventory is 94.36, which is 81% above median its 10-year median of 52.18 and 42% below the Drug Manufacturers industry median of 162.83. Universe Pharmaceuticals' overall GF Score™ is 58/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Days Inventory is 94.36 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universe Pharmaceuticals (UPC) Overvalued in 2026?
Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued.
The current stock price of $2.96 is trading 43.3% below its estimated GF Value™ of $5.22.
GuruFocus considers Universe Pharmaceuticals to be Possible Value Trap.
Key valuation signals for UPC:
Days Inventory: 94.36 (81% above median its 10-year median of 52.18)
GF Value™: $5.22 vs. price of $2.96 (43.3% below fair value)
Industry Position: 42% below the Drug Manufacturers median (#123 of 919)
No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
58GF Score
Get the complete analysis for UPC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UPC has been successfully added to your 
